Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma, Renal Cell × Anesthesia, Epidural × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Kidney Neoplasms 2 Prostatic Neoplasms 1 Pain 1 Intraoperative Complications 1 Colorectal Neoplasms 1 Carcinoma, Renal Cell 1 Arrhythmias, Cardiac 1 Anesthesia 1

Interventions

Sunitinib 72 Sorafenib 52 Everolimus 44 pazopanib 42 Nivolumab 42 Bevacizumab 39 pembrolizumab 31 aldesleukin 26 Interferon-alpha 26 temsirolimus 23 cabozantinib 19 Axitinib 19 Ipilimumab 16 Interleukin-2 15 Cyclophosphamide 15 fludarabine phosphate 13 Interferon alpha-2 13 Gemcitabine 13 Peripheral Blood Stem Cell Transplantation 10 Paclitaxel 10 Erlotinib Hydrochloride 10 Sirolimus 9 Docetaxel 8 Capecitabine 8 tremelimumab 7 lenvatinib 7 Radiosurgery 7 Fluorouracil 7 Fluorodeoxyglucose F18 7 Cyclosporine 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02030717 2015-06-04

ASA

Umeå University

Phase 2/3 Completed

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡